| 1 |
Protocol for the development of the international population registry for aphasia after stroke (I-PRAISE)
|
|
Ali, M.; Ben Basat, A. L.; Berthier, M.; Johansson, M. B.; Breitenstein, C.; Cadilhac, D. A.; Constantinidou, F.; Cruice, M.; Davila, G.; Gandolfi, M.; Gil, M.; Grima, R.; Godecke, Erin; Jesus, L.; Jiminez, L. M.; Kambanaros, M.; Kukkonen, T.; Laska, A.; Mavis, I.; Mc Menamin, R.; Mendez-Orellana, C.; Obrig, H.; Ostberg, P.; Robson, H.; Sage, K.; Van De Sandt-Koenderman, M.; Sprecht, K.; Visch-Brink, E.; Wehling, E.; Wielaert, S.; Wallace, S. J.; Williams, L. J.; Brady, M. C.
|
|
In: Research outputs 2014 to 2021 (2022)
|
|
Abstract:
Background: We require high-quality information on the current burden, the types of therapy and resources available, methods of delivery, care pathways and long-term outcomes for people with aphasia. Aim: To document and inform international delivery of post-stroke aphasia treatment, to optimise recovery and reintegration of people with aphasia. Methods & Procedures: Multi-centre, prospective, non-randomised, open study, employing blinded outcome assessment, where appropriate, including people with post-stroke aphasia, able to attend for 30 minutes during the initial language assessment, at first contact with a speech and language therapist for assessment of aphasia at participating sites. There is no study-mandated intervention. Assessments will occur at baseline (first contact with a speech and language therapist for aphasia assessment), discharge from Speech and Language Therapy (SLT), 6 and 12-months post-stroke. Our primary outcome is changed from baseline in the Amsterdam Nijmegen Everyday Language Test (ANELT/Scenario Test for participants with severe verbal impairments) at 12-months post-stroke. Secondary outcomes at 6 and 12 months include the Therapy Outcome Measure (TOMS), Subjective Index of Physical and Social Outcome (SIPSO), Aphasia Severity Rating Scale (ASRS), Western Aphasia Battery Aphasia Quotient (WAB-AQ), stroke and aphasia quality of life scale (SAQoL-39), European Quality of Life Scale (EQ-5D), lesion description, General Health Questionnaire (GHQ-12), resource use, and satisfaction with therapy provision and success. We will collect demography, clinical data, and therapy content. Routine neuroimaging and medication administration records will be accessed where possible; imaging will be pseudonymised and transferred to a central reading centre. Data will be collected in a central registry. We will describe demography, stroke and aphasia profiles and therapies available. International individual participant data (IPD) meta-analyses will examine treatment responder rates based on minimal detectable change & clinically important changes from baseline for primary and secondary outcomes at 6 and 12 months. Multivariable meta-analyses will examine associations between demography, therapy, medication use and outcomes, considering service characteristics. Where feasible, costs associated with treatment will be reported. Where available, we will detail brain lesion size and site, and examine correlations with SLT and language outcome at 12 months. Conclusion: International differences in care, resource utilisation and outcomes will highlight avenues for further aphasia research, promote knowledge sharing and optimise aphasia rehabilitation delivery. IPD meta-analyses will enhance and expand understanding, identifying cost-effective and promising approaches to optimise rehabilitation to benefit people with aphasia.
|
|
Keyword:
Aphasia; data collection; Medical Sciences; Medicine and Health Sciences; Neurosciences; outcome assessment; protocol; registry
|
|
URL: https://ro.ecu.edu.au/ecuworkspost2013/11451
https://ro.ecu.edu.au/cgi/viewcontent.cgi?article=12457&context=ecuworkspost2013
|
|
BASE
|
|
Hide details
|
|
|
| 2 |
Protocol for the development of the international population registry for aphasia after stroke (I-PRAISE)
|
|
|
|
BASE
|
|
Show details
|
|
|
| 3 |
Utilising a systematic review-based approach to create a database of individual participant data for meta- and network meta-analyses: the RELEASE database of aphasia after stroke
|
|
|
|
BASE
|
|
Show details
|
|
|
| 4 |
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis
|
|
|
|
BASE
|
|
Show details
|
|
|
| 6 |
Communicating simply, but not too simply: Reporting of participants and speech and language interventions for aphasia after stroke
|
|
|
|
BASE
|
|
Show details
|
|
|
| 7 |
RELEASE: A protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia
|
|
|
|
BASE
|
|
Show details
|
|
|
| 8 |
Tidier descriptions of speech and language therapy interventions for people with aphasia; consensus from the release collaboration
|
|
|
|
BASE
|
|
Show details
|
|
|
| 9 |
Aboriginal mitogenomes reveal 50,000 years of regionalism in Australia
|
|
|
|
BASE
|
|
Show details
|
|
|
| 10 |
Creating an international, multidisciplinary, aphasia dataset of individual patient data (IPD) for the REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE) project
|
|
|
|
BASE
|
|
Show details
|
|
|
| 11 |
A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome ...
|
|
|
|
BASE
|
|
Show details
|
|
|
| 12 |
A continuum of admixture in the Western Hemisphere revealed by the African Diaspora genome
|
|
|
|
BASE
|
|
Show details
|
|
|
| 13 |
Contextual behavioural coaching: An evidence-based model for supporting behaviour change
|
|
|
|
In: 11 ; 2 ; 142 ; 154 (2016)
|
|
BASE
|
|
Show details
|
|
|
| 14 |
Studying the family diet: an investigation into association between diet, lifestyle and weight status in Malaysian families
|
|
|
|
BASE
|
|
Show details
|
|
|
| 15 |
A Benign Paroxysmal Positional Vertigo Specialty Clinic: A Model for Va Health Care
|
|
|
|
In: ETSU Faculty Works (2013)
|
|
BASE
|
|
Show details
|
|
|
| 16 |
Basal insulin and cardiovascular and other outcomes in dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 319-328 (2012)
|
|
BASE
|
|
Show details
|
|
|
| 17 |
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
|
|
|
|
In: New England Journal of Medicine, vol. 367, no. 4, pp. 309-318 (2012)
|
|
BASE
|
|
Show details
|
|
|
| 18 |
Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children
|
|
|
|
BASE
|
|
Show details
|
|
|
| 19 |
40th EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004.
|
|
|
|
BASE
|
|
Show details
|
|
|
|
|
